Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation × dabrafenib × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 4 Melanoma 4 Thyroid Carcinoma, Anaplastic 2 Neoplasms 2 Hematologic Neoplasms 2 Glioma 2 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Laryngeal Neoplasms 1 Histiocytosis, Langerhans-Cell 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Erdheim-Chester Disease 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Astrocytoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡